Digirad (NASDAQ:DRAD) released its quarterly earnings results on Friday. The medical equipment provider reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.01), MarketWatch Earnings reports. The firm had revenue of $25.71 million for the quarter. Digirad had a negative return on equity of 6.52% and a negative net margin of 24.22%. Digirad updated its FY 2018 guidance to EPS.
NASDAQ:DRAD traded down $0.11 during mid-day trading on Friday, hitting $1.22. 258,652 shares of the stock were exchanged, compared to its average volume of 124,718. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.66 and a quick ratio of 1.22. Digirad has a fifty-two week low of $1.15 and a fifty-two week high of $3.05.
In other news, major shareholder Cannell Capital Llc purchased 68,594 shares of the company’s stock in a transaction that occurred on Tuesday, September 11th. The stock was acquired at an average cost of $1.75 per share, with a total value of $120,039.50. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 11.90% of the company’s stock.
A hedge fund recently raised its stake in Digirad stock. Renaissance Technologies LLC increased its position in shares of Digirad Co. (NASDAQ:DRAD) by 8.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 914,022 shares of the medical equipment provider’s stock after purchasing an additional 71,122 shares during the period. Renaissance Technologies LLC owned approximately 4.54% of Digirad worth $1,417,000 as of its most recent filing with the Securities and Exchange Commission. 54.84% of the stock is owned by hedge funds and other institutional investors.
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services.
Recommended Story: What does cost of debt say about a company’s financial health?
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.